Hosted on MSN
Global Vaccine Market Beckons India
When ideology overtakes pragmatism in crafting public policies, it portends danger to society. The recent decision by the Trump Administration to cancel $500 million in funding for mRNA vaccines, a ...
As dengue surges globally, an Indian vaccine candidate has entered the final stage of testing, raising hopes for one of the world's first single-dose shots against the deadly mosquito-borne disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results